Free white paper

The Patient Centricity Playbook

Get seven concrete strategies to open patient channels, build trust, run efficient engagements and close the loop with measurable impact. It’s our playbook for patient-centric engagement that your commercial team can deploy now.

Download the white paper

Patient-centered care is here. Operationalizing it is the gap.

Most teams agree on the why of patient centricity, yet struggle with the how. This guide translates a broad goal into a concrete operating rhythm across your commercial plan, addressing barriers like tech friction, privacy concerns, siloed data and scattered workflows.

It shows how to combine synchronous and asynchronous engagements, segment insights and report back so people see their input reflected in decisions.

This paper is written for pharma and life science commercial teams (and their agency or partner organizations) who want practical, actionable steps to embed patient engagement into their plans and workflows rather than just treating patient centricity as a vague goal or PR initiative.

The main idea

While “patient centricity” has been widely discussed in life sciences for years, most companies still lack a practical, standardized way to implement it. The paper argues that true patient centricity means systematically involving patients as active participants across the entire product lifecycle—not just as study subjects or PR talking points.

It defines patient centricity as a sustained, two-way practice where patients provide feedback, companies act on that input and then close the loop by showing how insights were incorporated.

To help teams operationalize this, we lay out seven concrete strategies commercial teams can use to build trust, address barriers, engage patients routinely, segment participation and report results back, ultimately embedding patient voices into everyday decision-making and company culture.

Take a peek inside What you’ll learn in this 12-minute read

A working definition of patient centricity your team can operationalize
7 “plays” to run across virtual boards, surveys and ongoing communities
How to blend synchronous and asynchronous engagement without extra lift
Ways to address tech, logistics and privacy hurdles while building trust
What to report back to patients and stakeholders to prove impact

Expert voices inside

Kelli Ray Group Account Director, MedThink Communications

Engaging patients in their own care empowers them to make better decisions for improving their lives.”

Belen Gonzalez Sutil, MA Associate Director, Patient Advocacy, Ultragenyx

At Ultragenyx, we understand the importance of incorporating the perspectives and needs of patients, caregivers, and advocates into each stage of drug development, systematically. By doing so, as a company, we can be confident that our programs are designed to meet the community’s needs.”

Trusted by leading pharma and life sciences teams focused on modern, scalable stakeholder engagement.

Get a copy

Let’s get this guide to you. Submit the form and we’ll email you a link. And don’t worry, we care about privacy as much as you do. No spam.

Submit the form to have it delivered to your inbox right now.